SAB Biotherapeutics SABS
NASDAQ SABS
$3.00 +0.18 (+6.38%)
As of: Oct 22, 2026 · 3:34 PM EDT

SAB Biotherapeutics (SABS) Ending Cash Balance (2020 - 2026)

Updated

Analysis

SAB Biotherapeutics (SABS) Ending Cash Balance (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,170.42 Bn 1,139.01 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 648.22 Bn 568.08 Bn 17.30 Bn 16.91 Bn
3 AbbVie 504.43 Bn 477.54 Bn 12.70 Bn 6.57 Bn
4 Merck 369.14 Bn 323.52 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 303.29 Bn 267.28 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 268.21 Bn 241.90 Bn 12.86 Bn 4.88 Bn
7 Amgen 242.56 Bn 197.96 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.91 Bn 169.11 Bn 6.22 Bn 3.18 Bn
9 Pfizer 173.28 Bn 119.92 Bn 10.94 Bn 1.03 Bn
10 SAB Biotherapeutics 239.26 Mn -178.24 Mn - 8.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.27 Mn
Mar 31, 2026 20.52 Mn
Dec 31, 2025 10.50 Mn
Sep 30, 2025 29.42 Mn
Jun 30, 2025 3.69 Mn
Mar 31, 2025 5.64 Mn
Dec 31, 2024 8.90 Mn
Sep 30, 2024 9.17 Mn
Jun 30, 2024 17.24 Mn
Mar 31, 2024 14.03 Mn
Dec 31, 2023 56.57 Mn
Sep 30, 2023 2.43 Mn
Jun 30, 2023 7.77 Mn
Mar 31, 2023 13.06 Mn
Dec 31, 2022 15.05 Mn
Sep 30, 2022 8.33 Mn
Jun 30, 2022 16.62 Mn
Mar 31, 2022 22.41 Mn
Dec 31, 2021 39.55 Mn
Sep 30, 2021 667,873.00
API Access

SAB Biotherapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=SABS&period=max&api_key=YOUR_API_KEY